Matches in Wikidata for { <http://www.wikidata.org/entity/Q70062972> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q70062972 description "article scientifique publié en 1987" @default.
- Q70062972 description "artikull shkencor i botuar më 01 janar 1987" @default.
- Q70062972 description "artículu científicu espublizáu en xineru de 1987" @default.
- Q70062972 description "scientific article published on 01 January 1987" @default.
- Q70062972 description "wetenschappelijk artikel" @default.
- Q70062972 description "наукова стаття, опублікована в січні 1987" @default.
- Q70062972 name "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-" @default.
- Q70062972 name "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 name "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 type Item @default.
- Q70062972 label "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-" @default.
- Q70062972 label "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 label "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 prefLabel "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-" @default.
- Q70062972 prefLabel "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 prefLabel "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 P1433 Q70062972-746D0C9C-CBA5-41DA-A344-E1592A6EBFA0 @default.
- Q70062972 P1476 Q70062972-5522E04E-29A2-4A19-BAF3-3D9534C31089 @default.
- Q70062972 P2093 Q70062972-0E28D55B-F4A1-48C4-88A0-93E86405E583 @default.
- Q70062972 P2093 Q70062972-96B6DC0F-4E43-4D56-8EB2-3D4D2219F2CC @default.
- Q70062972 P304 Q70062972-5B69495B-CFC1-40DD-93CA-7B5255C371C5 @default.
- Q70062972 P31 Q70062972-65532127-1FC3-42ED-B832-4054D722F0B4 @default.
- Q70062972 P433 Q70062972-CBD4329F-1A02-4280-99CC-308A9F427C5F @default.
- Q70062972 P478 Q70062972-7DEA0B50-82D4-4FF9-AC6D-30373DB04BB8 @default.
- Q70062972 P577 Q70062972-5A673459-986A-4D5A-8ABD-8CC979A16AA1 @default.
- Q70062972 P698 Q70062972-1EAA6798-C21E-42C7-BB46-00E7B82A24BA @default.
- Q70062972 P698 2972438 @default.
- Q70062972 P1433 Q20164692 @default.
- Q70062972 P1476 "[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]" @default.
- Q70062972 P2093 "Agolini G" @default.
- Q70062972 P2093 "Cavallini GM" @default.
- Q70062972 P304 "101-110" @default.
- Q70062972 P31 Q13442814 @default.
- Q70062972 P433 "2" @default.
- Q70062972 P478 "120" @default.
- Q70062972 P577 "1987-01-01T00:00:00Z" @default.
- Q70062972 P698 "2972438" @default.